Skip to content
Insider tapeFilings through Fri, Oct 2
Watchlist

Steven H Stein

Cmo & Head Of Late-Stage Dev. at Incyte Corp (INCY); Evp & Chief Medical Officer at Incyte Corp (INCY)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $7.9M

Reported trades

Filed Stock Type Shares Price Value Since
Jul 20SEC INCYIncyte Corp Sell Plan 1,877 $114.73 $215K -0.5%
Jul 16SEC INCYIncyte Corp Sell Plan 28,237 $113.05 $3.2M +1.0%
Jan 7SEC INCYIncyte Corp Sell Plan 15,634 $101.70 $1.6M +12.2%
Dec 3SEC INCYIncyte Corp Sell Plan 2,559 $102.96 $263K +10.8%
Dec 3SEC INCYIncyte Corp Sell Plan 20,105 $102.51 $2.1M +11.3%
Nov 7SEC INCYIncyte Corp Sell Plan 5,233 $102.20 $535K +11.7%
  • Sell

    Cmo & Head Of Late-Stage Dev. Steven H Stein sold $215K of INCY at $114.73 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Cmo & Head Of Late-Stage Dev. Steven H Stein sold $3.2M of INCY at $113.05 — cuts the stake by 52%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Medical Officer Steven H Stein sold $1.6M of INCY at $101.70 — cuts the stake by 31%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Medical Officer Steven H Stein sold $263K of INCY at $102.96 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Medical Officer Steven H Stein sold $2.1M of INCY at $102.51 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Evp & Chief Medical Officer Steven H Stein sold $535K of INCY at $102.20 — pre-scheduled 10b5-1 plan sale.